TGCT Support
  • Home
  • About TGCT
    • Causes of TGCT
    • Types of TGCT
    • Tumor Location
    • TGCT in Pediatrics
    • Diagnosis >
      • Biopsy
      • Imaging Features
  • Treatment
    • Surgery >
      • Recovery >
        • Surgery Guide
    • Medications >
      • Turalio >
        • Recommended Dosing
      • Romvimza
      • Imatinib
      • Common Side Effect of TGCT Drugs
    • Clinical Trials >
      • AMB-05X
      • Pimicotinib
      • Emactuzumab
      • Cabiralizumab
      • Lacnotuzumab
    • Radiation
  • Get Support
    • Join the Community >
      • Volunteer
      • Support Groups
    • TGCT Specialists
    • Consensus Guideline
    • Our Research
    • Nutrition
    • Pain Management
    • Mental Health >
      • Find Mental Health Help
    • Glossary of Terms
    • Educational Materials & Videos
    • Webinars
    • FAQs
  • News
    • Events
    • Patient Stories
  • About Us
    • Meet the Team
    • Medical Advisory Board
    • Partners >
      • TGCT Support France
    • Contact Us
    • Our Store
  • DONATE
    • GEM Program
  • Home
  • About TGCT
    • Causes of TGCT
    • Types of TGCT
    • Tumor Location
    • TGCT in Pediatrics
    • Diagnosis >
      • Biopsy
      • Imaging Features
  • Treatment
    • Surgery >
      • Recovery >
        • Surgery Guide
    • Medications >
      • Turalio >
        • Recommended Dosing
      • Romvimza
      • Imatinib
      • Common Side Effect of TGCT Drugs
    • Clinical Trials >
      • AMB-05X
      • Pimicotinib
      • Emactuzumab
      • Cabiralizumab
      • Lacnotuzumab
    • Radiation
  • Get Support
    • Join the Community >
      • Volunteer
      • Support Groups
    • TGCT Specialists
    • Consensus Guideline
    • Our Research
    • Nutrition
    • Pain Management
    • Mental Health >
      • Find Mental Health Help
    • Glossary of Terms
    • Educational Materials & Videos
    • Webinars
    • FAQs
  • News
    • Events
    • Patient Stories
  • About Us
    • Meet the Team
    • Medical Advisory Board
    • Partners >
      • TGCT Support France
    • Contact Us
    • Our Store
  • DONATE
    • GEM Program

News

What's new?


WE PRESENTED AT ASCO

The American Society of Clinical Oncology (ASCO)'s annual meeting is largest conference in the world. We presented registry data on pediatric patients with TGCT and we could not be prouder to demonstrate the unmet need for advancements in the management of TGCT for these young patients! Check it out!
Picture
Read it here

WE PUBLISHED OUR FIRST MEDICAL JOURNAL ARTICLE

Picture

2024 in Review


Check out our collaboration for a cme course

TGCT Support collaborated with PeerView to create a course for healthcare providers to learn more about the management of TGCT. Check it out and send to your providers: ​

Highlights from CTOS 2024


Picture
TGCT Support assisted in the dissemination of the results of the Vimseltinib MOTION trial,

​check it out




Read here

Watch our TGCT Day of Learning that occurred on July 27th, 2024 at 9:30-2:30pm MT in Aurora, Colorado
Watch it now
Picture

TGCT Day of Learning Conference was hosted in Rome, Italy! TGCT Support is going abroad for a chance to have a day of learning on April 20th, 2024! 

The half-day event will take place at 2-5pm CET at Precise House Mantegna Roma (Vía Andrea Mantegna, 130
00147, Rome, Italy). The event is free to patients and their families. 

WATCH NOW
Picture

TGCT Support submits a poster for the advocacy lounge at CTOS 
Picture
Check it out

TGCT was featured in an article written by Dr Sydney Stern about how patients can get involved with research
Read Here

Check out our upcoming TDOL on Sept 23rd, 2023 at 10-2:20pm ET in Columbus, Ohio at Ohio State University (James Cancer Center)  
Get More Information

Watch our "Best Clinical Management of TGCT as per the community of experts" webinar that goes through the latest consensus paper!
Watch HERE
Picture

Check out our latest TGCT Clinical Trials Webinar
Watch Here

Watch the TGCT Session at SPAN 2023 Conference
Watch Here

Picture
Read Here

2-Part Mental Health Series for Navigating Chronic Illness to Managing Chronic Pain and Symptoms
WAtch Here

Best clinical management of tenosynovial giant cell tumour (TGCT): a consensus paper from the community of experts
Expert Consensus on TGCT

Picture
TGCT Support is a global organization. Aligned with our mission, we have expanded our reach by assisting a French community of patients become established as an association. We are inspired by these patients and hope to continue to work together to bring resources to patients globally!

Check out all the CTOS 2022 Posters for TGCT
Characteristics of Turalio patients
Vimseltinib
Prelim results of ABSK021
TGCT Turalio Registry
Picture
Expert Q&A Webinar Live, here!
Picture
                     TGCT Support Announces its summer webinars! View our TGCT                             Expert Q&A flyer here and our Surgery and Pain Management                               flyer here

Picture
TGCT Support supports patients with video for Rare Disease Day

Watch here 

Picture
First Western US to open Phase 3 for Vimseltinib 

​Check it out here



Picture
Director of Giant Cell Tumor Programs at TGCT Support, Sydney Stern, gives an overview of TGCT for CheckRare

​                       Check it out!


Picture
AmMax Bio announces positive results during AMB-05X Phase 2 trial of local injections to the knee

                           Learn more here


Picture
DCC-3014 (Vimseltinib) launches its Phase 3 Trial

Learn more here

Picture
TGCT Support Launches Support Groups!

Check it out here
​

Picture
National Organization for Rare Diseases (NORD) updates their TGCT page
​
Check it out here


Picture
AmMax Bio Announces First Patient Enrolled in Phase 2 Trial of AMB-05X for Tenosynovial Giant Cell Tumor (TGCT)

Read more here

Picture
CancerCare® Publishes White Paper Highlighting Gaps in Education and Care for Patients with Tenosynovial Giant Cell Tumors (TGCT)

Read more here


Picture
DCC-3014 (vimseltinib) shows promise as a new selective treatment for TGCT

Read more here

Picture
New Clinical Trial from AmMax Bio for an intra-articular joint injection for TGCT patients

Read more here

TGCT SUPPORT IS A PROGRAM OF THE LIFE RAFT GROUP

Picture
155 US Highway 46, Suite 202                      Wayne, NJ 07470                      [email protected]